Severe persistent mycobacteria antigen stimulation causes lymphopenia through impairing hematopoiesis
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1079774 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Fei Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gansu Provincial Key Laboratory of Evidence-Based Medicine and Clinical Translation and Lanzhou Center for Tuberculosis Research, Institute of Pathog…. Hauptthemen laut MEDLINE: Tuberculosis, Mycobacterium tuberculosis, Mycobacterium bovis, Lymphopenia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Miliary tubersculosis (TB), an acute systemic blood disseminated tuberculosis mainly caused by Mycobacterium tuberculosis ( M. tuberculosis ), can cause signs of lymphopenia in clinical patients. To investigate whether/how persistent mycobacteria antigen stimulation impairs hematopoiesis and the therapeutic effect of interleukin-7 (IL-7), a mouse model of Mycobacterium Bovis Bacillus Calmette-Guérin (BCG) intravenous infection with/without an additional stimulation with M. tuberculosis multi-antigen cocktail containing ESAT6-CFP10 (EC) and Mtb10.4-HspX (MH) was established. Consistent with what happened in miliary TB, high dose of BCG intravenous infection with/without additional antigen stimulation caused lymphopenia in peripheral blood. In which, the levels of cytokines IFN-γ and TNF-α in serum increased, and consequently the expression levels of transcription factors Batf2 and IRF8 involved in myeloid differentiation were up-regulated, while the expression levels of transcription factors GATA2 and NOTCH1 involved in lymphoid commitment were down-regulated, and the proliferating activity of bone marrow (BM) lineage - c-Kit + (LK) cells decreased. Furthermore, recombinant Adeno-Associated Virus 2-mediated IL-7 (rAAV2-IL-7) treatment could significantly promote the elevation of BM lymphoid progenitors. It suggests that persistent mycobacteria antigen stimulation impaired lymphopoiesis of BM hematopoiesis, which could be restored by complement of IL-7.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gansu Provincial Key Laboratory of Evidence-Based Medicine and Clinical Translation and Lanzhou Center for Tuberculosis Research, Institute of Pathogen Biology, School of Basic Medical Sciences, Lanzhou University, Lanz…
- Inpatient Ward 1, Lanzhou Pulmonary Hospital, Lanzhou, China.
- Institute of Pathophysiology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
- Department of Clinical Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, China.
- State Key Laboratory of Veterinary Etiological Biology, College of Veterinary Medicine, Lanzhou University, Lanzhou, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Li, F., Ma, Y., Li, X., Zhang, D., Han, J., Tan, D., Mi, Y., Yang, X., Wang, J., & Zhu, B. (2023). Severe persistent mycobacteria antigen stimulation causes lymphopenia through impairing hematopoiesis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1079774
Vancouver
Li F, Ma Y, Li X, Zhang D, Han J, Tan D, et al. Severe persistent mycobacteria antigen stimulation causes lymphopenia through impairing hematopoiesis. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1079774
BibTeX
@article{Li2023,
author = {Li, Fei and Ma, Yanlin and Li, Xiaoping and Zhang, Dan and Han, Jiangyuan and Tan, Daquan and Mi, Youjun and Yang, Xiaojuan and Wang, Juan and Zhu, Bingdong},
title = {Severe persistent mycobacteria antigen stimulation causes lymphopenia through impairing hematopoiesis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1079774}
}
EUVIMED